Article Versions Notes

Jimenez C, Armaiz-Pena G, Dahia PLM, Lu Y, Toledo RA, Varghese J, Habra MA. Endocrine and Neuroendocrine Tumors Special Issue—Checkpoint Inhibitors for Adrenocortical Carcinoma and Metastatic Pheochromocytoma and Paraganglioma: Do They Work? Cancers. 2022; 14(3):467. https://doi.org/10.3390/cancers14030467

Jimenez, Camilo, Gustavo Armaiz-Pena, Patricia L. M. Dahia, Yang Lu, Rodrigo A. Toledo, Jeena Varghese, and Mouhammed Amir Habra. 2022. "Endocrine and Neuroendocrine Tumors Special Issue—Checkpoint Inhibitors for Adrenocortical Carcinoma and Metastatic Pheochromocytoma and Paraganglioma: Do They Work?" Cancers 14, no. 3: 467. https://doi.org/10.3390/cancers14030467

Jimenez, C., Armaiz-Pena, G., Dahia, P. L. M., Lu, Y., Toledo, R. A., Varghese, J., & Habra, M. A. (2022). Endocrine and Neuroendocrine Tumors Special Issue—Checkpoint Inhibitors for Adrenocortical Carcinoma and Metastatic Pheochromocytoma and Paraganglioma: Do They Work? Cancers, 14(3), 467. https://doi.org/10.3390/cancers14030467